Trials of biannual injections to prevent HIV infection have begun in the US
The US National Institutes of Health (NIH) announced in a press release the initiation of two clinical trials of lenacapavir for the pre-exposure prophylaxis of human immunodeficiency virus (HIV) infection
06.06.2024